Thursday, 3 June 2021

Single Cell Analysis - latest papers using DRAQ7

DRAQ™ dyes have become a standard tool in FACS sample preparation for downstream molecular analysis (e.g. snATAC, GWAS, RNAseq, etc.) 

Here are recent references to DRAQ7:

Single cell suspensions were generated from fresh prostate tissue and prepared for BD Biosciences Rhapsody analysis with Calcein AM and DRAQ7 used to evaluate dead/damaged cell numbers prior to the cell sort.  This work uncovered a transcriptomic remodelling associated with disease progression. 

Chen, Sujun, et al. "Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression." Nature Cell Biology 23.1 (2021): 87-98.

In pursuit of a fuller understanding of the regulators of differentiation of the neutrophil lineage pathway Schwaber et al. (Univ. of Queensland / Avectas / Bluerock Therapeutics) sorted cells for single cell transcriptomics and differentiated progenitors to granulocytes-macrophage cultures for a timed series of proteomic analyses.

The sorting panel was composed of antibody-conjugated fluorophores PE, PerCP-Cy5.5, FITC/AF488, PacificBlue, and BV421. Dead cells were excluded using DRAQ7

Gated IL-3Rα low,CD45RA+ GMP populations were isolated for RNA extraction (Day 0) and the remaining GMPs were used for initiating granulocyte cultures.

Schwaber, Jessica L., et al. "Network mapping of primary CD34+ cells by Ampliseq based whole transcriptome targeted resequencing identifies unexplored differentiation regulatory relationships." PloS one 16.2 (2021): e0246107.

An unprecedented and major study to map the accessible chromatin of 25 different tissues in the human body has been carried out by a team from UCSD and Ludwig Inst for Cancer Research.  They optimised the harvesting of nuclei from each tissue sample and sorted nuclei to enable snATAC sequencing, gathering data on 470,000+ individual nuclei and categorized these into 54 major cell types.  To trigger the sorting of single nuclei for downstream analysis, they were labeled with DRAQ7.

Zhang, Kai, et al. "A cell atlas of chromatin accessibility across 25 adult human tissues." bioRxiv (2021). DOI:10.1101/2021.02.17.431699

WHERE TO BUY

Related BioStatus blogposts and white papers:

Myth-busting DNA dyes and single cell sorts (September 2023)

Quick and Gentle Nuclei Prep and Sorting (June 2021)

Sample Prep for Single Cell Transcriptomics & Genomics (November 2019)

Imaging Flow Micronucleus Test - inter-laboratory comparison

The earlier demonstrations of the capability of the imaging flow cytometer to provide an unattended, automated analysis for chemical genotoxicity or radiation exposure has now been supported by an inter-laboratory comparison study by scientists at GSK, Broad Institute and Swansea, Cardiff, Newcastle, and Cambridge Universities.

They demonstrated that the procedures on the Amnis Imagestream, which included DRAQ5 as a DNA counterstain, were robust across the different protocols and sites involved.

This now has the strong potential to change the approach to genotoxicity testing away from late stage development and to bring it further back in the drug discovery pipeline, to discover unsuitable structures earlier in the process. 

WHERE TO BUY

Reference:

Wills, John W., et al. "Inter-laboratory automation of the in vitro micronucleus assay using imaging flow cytometry and deep learning." Archives of Toxicology. Vol 95, pp 3101–3115 (2021)

Related BioStatus blogposts:

Automated Micronucleus Test (MNT)...

New DRAQ5 citations in drug discovery (see Imagestream/FlowSight section)



CODEX Multiplex Imaging with DRAQ5

The powerful technique "CODEX" recently developed by the Stanford University laboratory of Garry Nolan enables multiplex imaging (and therefore deep phenotyping) of single biological samples of solid tissue, using iterative cycles of labeling compatible with a standard fluorescence microscope.

In two recent examples the inventing laboratory has utilised DRAQ5 as the nuclear counterstain, detected in the "Cy5" filter channel.  DRAQ5 was applied in the final cycle at 50 µM (consistent with the concentration used in rapid histopathology analyses and on FFPE sections elsewhere).

DRAQ5's expected performance in this application opens up new panel design combinations and broadens microscope compatibility 

WHERE TO BUY

References:

Goltsev, Yury, et al. "Deep profiling of mouse splenic architecture with CODEX multiplexed imaging." Cell 174.4 (2018): 968-981.

Phillips, Darci, et al. "Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma." medRxiv (2020). DOI: 10.1101/2020.12.06.20244913

Better assay for free drug concentrations

It is well understood that small molecule drugs are bound by plasma proteins.  This plasma protein binding (PPB) varies dramatically from compound to compound and is determined indirectly as a 'PPB adjusted' IC₅₀.  Despite the inaccuracies of this PPB adjusted IC₅₀ the alternative gold standard of in vivo measurement of free drug is complex and therefore restricted to late optimization stages of drug development.

Scientists at Prelude Therapeutics and Locanabio have built on the well-described and widely used in-cell western assay (ICW) to develop a direct, sensitive and quantitative measurement of drug potency in the presence of plasma protein using the model of protein kinase inhibitors on target cells.  The assay format is suitable for both adherent and non-adherent cells and for drugs which display their maximal response in under 6 hours and where expression/modification of a protein is affected by the drug treatment (acting as the reporter).

The reporter for the protein kinase inhibitor was RNA pol II B1 detected by antibody and fluorescence.  The far-red DNA dye DRAQ5 (optimized at 2.5 µM final concentration in blocking buffer with IRdye 800CW-tagged secondary antibody, incubated for 1h at RT) was used to normalise cell number between the plate wells.  Plates were scanned using the LICOR Odyssey Imaging system.  The whole process is complete in 2 days for suspension cells and 3 days for adherent cells (1 day for adherence).

Importantly, the data for a list of compounds tested show striking discrepancies between the PPB adjusted IC₅₀ and this direct functional cell-based assay, with the latter showing good accord with other reports in the literature for the reference compound used.  

This automatable high throughput ICW assay format is amenable to earlier phases of the drug discovery process due to its simplicity, speed. It is both quantitative and sensitive.

WHERE TO BUY

Reference:

Zhang, Yang W., et al. "Human Plasma In‐Cell Western Assays—An In vitro Predictor for In vivo Pharmacology in Oncology Drug Discovery." Current Protocols 1.2 (2021): e51.

Related blogposts:

Assaying for Virus Neutralizing Antibodies. Dec. 15, 2020



Wednesday, 2 June 2021

Clear sense - optical clearing of microtissues, tissue slices

To better understand cell biology in a more physiologically-relevant context we have progressively moved to the use of 3D cell culture in place of 2D adherent cells on plastic.  These spheroids and microtissues (e.g. organoids) can be derived from single cell lines, progenitor cells, or increasingly also co- and tri-cultures to further increase relevance.  This immediately challenges the technical limits of confocal and light sheet microscopy due to the level of light scatter, signal loss and related signal:noise ratio that all significantly impacting on the ability to interrogate beyond a few cell layers.  This is also the case for tissues and for whole organs from animal models.  

To deal with these challenges a wide range of tissue clearing methods have been developed in recent years.  However, these have created confusion and none have proved themselves suitably universal necessitating more work to determine best fit of method with cell type, culture system or tissue.  Likewise, the choice of nuclear counterstain has been at issue and the point in the protocol at which addition should occur.

Recent papers have sought to improve this situation, and demonstrate that DRAQ5™ has broad utility as a reliable nuclear counterstain in tissue clearing protocols.  An example of the use of DRAQ7™ as a counterstain in the CLARITY procedure is also described.

WHERE TO BUY

A broad systematic study from the University of Freiburg (Nürnberg et al.) compared 4 different clearing methods (representative of the common types) against a range of single-cell / tri-cell derived spheroids and co-cultures generated in cavities with different fluorescent readouts for nuclei (DAPI, DRAQ5), proliferation Ki-67, ECFP as constitutive marker and CellTracker dyes. Imaging was performed with confocal microscopy.

In summary, the major conclusions of this work were that tri-cultures proved the most challenging perhaps due to increased cell packing and ECM where no clearing method met the Rose Criterion beyond 90 µm, and where only DAPI was tested as counterstain. ECFP was highly sensitive to all clearing methods.

Results were better in the single-cell and co-culture models, meeting the Rose Criterion (SNR >5) beyond 200 µm when combining glycerol or ScaleS clearing methods with DRAQ5 as nuclear counterstain (which was consistent for all clearing methods).  Results were consistently poorer with DAPI and with the other clearing methods - Cytovista, ClearT2 - and referenced against Mowiol and PBS. Additionally Cytovista caused significant shrinkage of the spheroids (necessitating a halving of the z-section depth) while DAPI performed particularly badly in PBS and ClearT2.  These results were mostly independent of the cell line used.

In addition to clearing it was also determined that z-compensation was required to achieve good segmentation of nuclei and obtain a quantitative analysis.

Overall, RI-matched 88% glycerol was the simplest and quickest method, performing best overall. Interestingly, the next best was ScaleS where clearing was performed prior to (immuno-) fluorescent stainings unlike the 3 alternatives. 

Nürnberg, Elina, et al. "Routine Optical Clearing of 3D-Cell Cultures: Simplicity Forward." Frontiers in Molecular Biosciences 7 (2020): 20.

In other work on neutrophil recruitment in Triple-Negative Breast Cancer, SenGupta et al. (Univ. Michigan) generated spheroids by the hanging drop method.  4-day spheroids were DRAQ5-stained (5µM, o/n, 4 degC) and then cleared with FOCM (1-5 min.; ultra-fast optical clearing method, Zhu et al. PNAS 2019) and then imaged by 2-photon microscopy at 1040 nm excitation.  FOCM apparently limits expansion/shrinkage and can be used as mounting medium. 

SenGupta, Shuvasree, et al. "Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands." Frontiers in immunology 12 (2021): 973.

Mir-Coll et al. (Karolinska Inst.) generated pancreatic islet microtissues by a hanging drop method. For analysis they were first stained with DRAQ5 for 2h and then fixed. Thereafter they were cleared with Visikol HISTO (Visikol) and imaged for Cerulean, EGFP, DsRed2 and DRAQ5 fluorescence by confocal microscopy. 

Mir-Coll, Joan, et al. "Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes." International Journal of Molecular Sciences 22.4 (2021): 1813.

In pursuit of standardising comparison of different clearing methods Diosdi et al. (Univ. Szeged) compared spheroids generated with three different carcinoma cell lines and with five clearing protocols (ClearT, ClearT2, CUBIC, ScaleA2, and Sucrose), subsequently stained with DRAQ5 and imaged under identical settings by light sheet microscopy.  The resulting images were subjected to experts' evaluation and scored accordingly. ClearT and ClearT2 could not be separated from uncleared controls but also caused significant shrinkage. CUBIC, ScaleA2, and Sucrose gave better results though these varied by cell line. Sucrose caused no overall volumetric change while both CUBIC and ScaleA2 caused some swelling. 

DRAQ5 was compatible with all combinations. Interestingly, DRAQ5 was used in PBS for ClearT, ClearT2 and Sucrose and in 4M urea for CUBIC and ScaleA2. This aids its compatibility with multiple protocols and therefore simplifies the decision on choice of chromophores that can be relied upon to perform well, irrespective of the chosen sample preparation methodology.

Diosdi, Akos, et al. "A quantitative metric for the comparative evaluation of optical clearing protocols for 3D multicellular spheroids." Computational and Structural Biotechnology Journal 19 (2021): 1233-1243.

A simple protocol for the in situ imaging of kidney across length scales has been proposed by Unnersjö-Jess, et al. (Cologne, Stockholm).  The whole nephrectomised organ (mouse/human) was fixed, sectioned to 300 µm slices, followed by an accelerated delipidation (SDS/boric acid, 1h, 70 degC), labeling with antibodies and DRAQ5 as counterstain (10 µM in PBST, 2h, 37 degC) and mounting in fructose/4M urea before imaging from 100X confocal microscopy to conventional immunofluorescence and histology.

Unnersjö-Jess, David, et al. "A fast and simple clearing and swelling protocol for 3D in-situ imaging of the kidney across scales." Kidney International 99.4 (2021): 1010-1020.

To determine the location of therapeutic human adipose mesenchymal stromal cells (hAMSCs) in a study of the performance of fast-growing cells alongside ganciclovir researchers in Barcelona used a modified CLARITY clearing procedure to analyse brain slices, in a rodent model of treated human glioblastoma infused with GFP-U87 cells and later RFP-hAMSCs.  In vivo hydrogel-infused brain slices were cleared by delipidation with SDS/boric acid (4 days, 45 degC) and then mounted between slide and coverslip. DRAQ7 was used as nuclear counterstain, suited due to the DRAQ chromophore's spectral compatible with GFP and RFP.  This technique enabled 3D analysis to a depth of 200 µm.

Guerra-Rebollo, M, et al. "Glioblastoma bystander cell therapy: improvements in treatment and insights into the therapy mechanisms." Molecular Therapy-Oncolytics 11 (2018): 39-51.

WHERE TO BUY


Tuesday, 1 June 2021

Correlative microCT and EM enabled by CyGEL mountant

In a comprehensive study to evaluate the properties of transplantable patient-derived gut organoids scientists at The Francis Crick Institute, Great Ormond Street Hospital and UCL used a suite of analyses, ranging from metabolic, biochemical and multi-lengthscale and multi-feature imaging techniques.  

In one iteration, they combined µCT and TEM/SBF-SEM/SEM montage. µCT was used to check the orientation of the cells on recellularized scaffolds prior to onward processing for electron microscopy.  To achieve this in a non-destructive manner that maintained the spatial integrity and orientation of the cellular objects and the scaffold, the fixed re-cellularized scaffolds were mounted in the thermo-reversible mounted CyGEL™. After CT scanning the sample was placed in ice to gently wash away the CyGEL and thereby recovered for onward EM processing.

This is the first demonstration of the use of CyGEL in µCT and in a correlative imaging technique. This transparency to x-rays, in addition to CyGEL's purpose-designed compatibility with fluorescence microscopy, give it great utility in multi-modal imaging techniques.

WHERE TO BUY

Reference:

Meran, Laween, et al. "Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure." Nature Medicine 26.10 (2020): 1593-1601.

Links to related blogposts on correlative microscopy techniques:

CryoChem - from fluorescence to µCT to SBEM

ChromEMT - labeling chromatin

Simplified CLEM method - from in vivo imaging to FIB/SEM

Multi-scale tissue analysis: hybrid fluorescence-AFM